Sector consensus Cardiol Therapeutics Inc.
Stocks
CRDL
CA14161Y2006
Biotechnology & Medical Research
|
Market Closed -
Toronto S.E.
06:00:00 19/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 2.610 CAD | -1.14% |
|
-5.09% | +99.24% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 6 | +127.27% | 2 | |||||||
| 688.17 | +26.27% | 23 | |||||||
| 277.94 | +3.16% | 18 | |||||||
| 251.21 | +27.56% | 20 | |||||||
| 432.8 | +22.45% | 28 | |||||||
| 268,686.76 | +49.02% | 22 | |||||||
| 581.83 | -5.42% | 12 | |||||||
| 270.95 | +30.8% | 20 | |||||||
| 72.24 | -6.03% | 14 | |||||||
| 185.25 | +9.18% | 16 | |||||||
| 282.43 | +0.27% | 14 | |||||||
| 68.18 | -15.16% | 17 | |||||||
| 70.73 | -2.32% | 11 | |||||||
| 50.57 | +15.59% | 11 | |||||||
| 137.73 | +16.25% | 22 | |||||||
| 174.69 | +21.57% | 13 | |||||||
| 137.98 | +47.25% | 7 | |||||||
| 3.908 | -17.62% | 7 | |||||||
| 46.27 | +4.25% | 15 | |||||||
| 638.68 | +105.72% | 19 | |||||||
| Average | 13,653.22 | +23.00% | 16 | ||||||
| Weighted average by Cap. | 21,844.5 | +18.36% | 19 |
- Stock Market
- Stocks
- CRDL Stock
- Sector Cardiol Therapeutics Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















